Mycophenolic acid and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Mycophenolic acid (mycophenolic acid), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Neoral, and have Fungal infection.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Mycophenolic acid. It is created by eHealthMe based on reports of 16,218 people who have side effects when taking Mycophenolic acid from the FDA, and is updated regularly.

What is Mycophenolic acid?

Mycophenolic acid has active ingredients of mycophenolic acid. eHealthMe is studying from 16,233 Mycophenolic acid users. Check the latest studies of Mycophenolic acid.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 940 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

On Jul, 13, 2026

16,218 people reported to have side effects when taking Mycophenolic acid.
Among them, 13 people (0.08%) have Thrombophlebitis.

Could Mycophenolic acid cause Thrombophlebitis?

Among these 13 people:

How long have people been on Mycophenolic acid when they have Thrombophlebitis? *

What is the gender of people who have Thrombophlebitis when taking Mycophenolic acid? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Thrombophlebitis when taking Mycophenolic acid? *

What are other drugs people take besides Mycophenolic acid? *

What are other side effects people have besides Thrombophlebitis? *

Weakness: 4 people, 30.77%
Pain In Extremity: 4 people, 30.77%
Rashes (redness): 4 people, 30.77%
Septic Shock (shock due to blood infection): 3 people, 23.08%
Drug Ineffective: 3 people, 23.08%
Oedema Peripheral (superficial swelling): 3 people, 23.08%
Pneumonia: 3 people, 23.08%
Joint Pain: 3 people, 23.08%
Urinary Tract Infection: 3 people, 23.08%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 15.38%

What are the existing conditions these people have? *

Lung Disorder (lung disease): 2 people, 15.38%
Fungal Infection: 2 people, 15.38%
Vasculitis (inflammation of a blood vessel or blood vessels): 1 person, 7.69%
Type 2 Diabetes: 1 person, 7.69%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 7.69%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 7.69%
Renal Impairment (severely reduced kidney function): 1 person, 7.69%
Pneumonia: 1 person, 7.69%
Immunodeficiency Disorders: 1 person, 7.69%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolic acid and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolic acid:

Mycophenolic acid (16,233 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Mycophenolic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (940 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolic acid (the active ingredients of Mycophenolic acid) and Mycophenolic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.